Annual Lung SPORE Workshop (Abstract Submission): Submission #42

Submission information
Submission Number: 42
Submission ID: 110524
Submission UUID: 542643b1-88d8-4c85-af96-06197d7cfac2

Created: Mon, 03/11/2024 - 09:40
Completed: Mon, 03/11/2024 - 10:03
Changed: Thu, 05/09/2024 - 11:44

Remote IP address: 10.208.24.212
Submitted by: Anonymous
Language: English

Is draft: No
Francisco
Exposito
{Empty}
Yale Cancer Center
Investigating Lkb1 loss as novel synthetic vulnerability in EGFR-driven lung cancer
First Author
Francisco
Exposito
Yale Cancer Center, New Haven; Yale School of Medicine, New Haven, USA
Additional Authors
  • First Name: Emily
    Last Name: Shuldiner
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Steven
    Last Name: Lopez
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Minwei
    Last Name: Wang
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Mariana
    Last Name: Do Carmo
    Affiliation: Department of Pathology, Yale School of Medicine, New Haven, CT, USA
  • First Name: Laura
    Last Name: Andrejka
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Giorgia
    Last Name: Foggetti
    Affiliation: Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • First Name: Christopher
    Last Name: W. Murray
    Affiliation: Department of Genetics, Stanford University, Stanford, California 94305, USA
  • First Name: Dimitri
    Last Name: Petrov
    Affiliation: Department of Biology, Stanford University, Stanford, California 94305, USA
  • First Name: Monte
    Last Name: Winslow
    Affiliation: Division of Oncology, Department of Medicine / Stanford Cancer Institute / Department of Pathology, Stanford University School of Medicine, Stanford, California
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Department of Pathology, Yale School of Medicine / Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Session 1: Oncogene-driven lung cancers and resistance to targeted therapies
No
Approved to be a Poster Presenter
{Empty}
Poster Submission
{Empty}